Switch to:
More From Other Websites
Up to Speed: Peltz receives ammo in fight against DuPont (Video) Jan 28 2015
Will Baxter International (BAX) Disappoint Earnings in Q4? - Analyst Blog Jan 27 2015
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog Jan 26 2015
CareFusion Banks on Pipeline Strength, Pricing Woes Remain - Analyst Blog Jan 26 2015
Merrimack Reveals Additional Data from Oncology Candidate - Analyst Blog Jan 22 2015
Baxter's (BAX) PHOXILLUM Solutions Get FDA Nod for CRRT - Analyst Blog Jan 21 2015
Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous... Jan 20 2015
Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous... Jan 20 2015
Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the... Jan 20 2015
PharmaEngine Announces Expanded Analyses of Phase 3 MM-398 NAPOLI-1 Study Presented at the 2015 ASCO... Jan 19 2015
Baxter Offers Yield In Hot Medical Products Group Jan 16 2015
Saline Solution Shortages Drove Non-Sterile Intravenous Fluid Debacle Jan 15 2015
Palmetto Health in Columbia, South Carolina, Receives Prestigious $100,000 Foster G. McGaw Prize for... Jan 15 2015
NxStage Revises Up 2014 Guidance on Strong Home Growth - Analyst Blog Jan 14 2015
BAXTER INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 09 2015
Blue Chips For A New Year Jan 07 2015
Pfizer continues vaccine push, buys Switzerland's Redvax Jan 05 2015
Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment... Dec 22 2014
Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment... Dec 22 2014
Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment... Dec 22 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Sww
ReplySww - 6 months ago
Bax medical devices revenue ~9b, bio science ~7b
using 3X sales of medical devices company and 4X for drugs company, 27b+28b = 55b market cap,as of June 2014, BAX market cap is 39b, so it can sell for

72 * (1 + 16/39) = 99

72 is current stock price, with an upside of around 35%

so my guess is BAX may be able to sell for around 90 after spin-off.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK